|
Patients Fear Spike in Price of Old Drugs
New York Times “The Orphan Drug Act was intended to promote new drug development, not price gouging of old drugs,” Dr. Makary said. Catalyst’s chief executive, Patrick J. McEnany, said in an interview that the company would offer financial assistance to any patients … and more |